Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00902447 · ClinicalTrials.gov registry record

Human Blood Cell Disorders Tissue Bank

A clinical trial of Human Blood Cell Disorders and Lymphoid, Myeloid and Erythroid Proliferative Disease, sponsored by Northwell Health.

Recruiting
Registry status
10,000
Enrollment target
1
Study location

NCT00902447: Recruiting study of Human Blood Cell Disorders and Lymphoid, Myeloid and Erythroid Proliferative Disease, sponsored by Northwell Health.

NCT00902447 is a study of Human Blood Cell Disorders and Lymphoid, Myeloid and Erythroid Proliferative Disease that is actively recruiting participants, run by Northwell Health. The registered enrollment target is 10,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00902447, a study of Human Blood Cell Disorders and Lymphoid, Myeloid and Erythroid Proliferative Disease, is actively recruiting participants, sponsored by Northwell Health.

RECRUITING
Registry status
10,000 participants
Enrollment target
1
Study location

Study Summary

The Human Blood Cell Disorder Tissue Bank will provide a convenient, comprehensive source of tissue containing populations of human blood cells from patients with various types of lymphoid, myeloid, and erythroid proliferative diseases as well as other associated conditions. The tissue bank will continue to be an invaluable asset for understanding of the biology of multiple blood cell disorders involving several cell types as well as the physiology of normal cellular counterparts affected in these disorders. Internal and external investigators will be able to utilize this tissue to test hypotheses relating to the immunologic, virologic, genetic, and molecular properties of these abnormal cells as well as normal cells from normal unaffected family members or normal aged matched subjects to provide better comparisons.

Study Locations (1)

New York

  • The Feinstein Institute for Medical Research - Manhasset

Trial Details

FieldValue
Enrollment Target 10,000 participants
Start Date 2009-04
Est. Completion 2035-01
Northwell Health

370 total trials

What NCT00902447 shows while recruiting

NCT00902447 is an observational study that tracks outcomes without assigning an intervention. Its 10,000 participants enrollment target places it among the larger protocols in the corpus.

The record links to 2 conditions, with Human Blood Cell Disorders appearing as the primary indexed condition, and to 0 interventions.

NCT00902447 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT00902447 about?

NCT00902447 is a clinical study titled "Human Blood Cell Disorders Tissue Bank". The Human Blood Cell Disorder Tissue Bank will provide a convenient, comprehensive source of tissue containing populations of human blood cells from patients with various types of lymphoid, myeloid, and erythroid proliferative diseases as well as other associated conditions. The tissue bank will con...

What is the current status of trial NCT00902447?

This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2009-04. Estimated completion is 2035-01.

What conditions does trial NCT00902447 study?

This clinical trial studies the following conditions: Human Blood Cell Disorders, Lymphoid, Myeloid and Erythroid Proliferative Disease.

Who is sponsoring clinical trial NCT00902447?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00902447 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00160771 · 10,000 participants

    Biomechanics/Motion Analysis Laboratory Data Bank

  • NCT00896935 · 10,000 participants

    Arizona Cancer Center Biospecimen Repository

  • NCT00898235 · 10,000 participants

    Collection of Samples and Clinical Data From Patients With Amyloid Diseases

  • NCT00992303 · 10,000 participants

    Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00902447, the US trial registry maintained by the National Library of Medicine. NCT00902447 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.